Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Plus Therapeutics, Inc. (PSTV) had Stock-Based Compensation of $1.54M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.37M |
|
$-5.71M |
|
-- |
|
$1.37M |
|
$7.11M |
|
$-5.74M |
|
$0.03M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.74M |
|
$-5.60M |
|
3.11M |
|
3.11M |
|
$23.00 |
|
$23.75 |
|
| Balance Sheet Financials | |
$15.17M |
|
$0.26M |
|
$1.16M |
|
$16.32M |
|
$12.31M |
|
-- |
|
$0.01M |
|
$12.33M |
|
$4.00M |
|
$3.29M |
|
$4.00M |
|
5.55M |
|
| Cash Flow Statement Financials | |
$-20.77M |
|
$-0.85M |
|
$30.31M |
|
$0.08M |
|
$8.76M |
|
$8.68M |
|
|
Stock-Based Compensation |
$1.54M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
100.00% |
|
-420.04% |
|
-420.04% |
|
-- |
|
-417.92% |
|
-417.92% |
|
$-20.81M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
4.25 |
|
21.20 |
|
-142.97% |
|
-173.59% |
|
-35.00% |
|
-142.97% |
|
$0.72 |
|
$-6.69 |
|
$-6.68 |
|